title: Conservative treatment of congenital dacryocele.
abstract: OBJECTIVE
  To study prospectively the effectiveness of medical management of congenital dacryoceles.
  
  
  METHODS
  All patients presenting with congenital dacryocele that were not infected were treated with warm compresses, massage, and topical antibiotics. Dacryoceles that did not resolve with at least two weeks of medical management were probed. Dacryoceles that were infected were treated with intravenous (IV) antibiotics in addition to warm compresses and massage.
  
  
  RESULTS
  Seventeen patients with 21 dacryoceles were studied over a 3 1/2-year period. All patients were examined by the authors and treatment was initiated prior to 3 weeks of age. Sixteen dacryoceles resolved with medical management in 1 to 6 days. Three of these 16 dacryoceles were infected and patients were hospitalized at the time of initial ophthalmic evaluation (2 to 4 days of life). One additional dacryocele became infected after 2 days of medical management (4th day of life), requiring hospital admission and IV antibiotics. All four infected dacryoceles resolved within 24 hours of the initiation of IV antibiotics, warm compresses, and massage. Five dacryoceles were probed after not resolving within 14 to 31 days of medical management. One dacryocele required a repeat probing.
  
  
  CONCLUSIONS
  Medical management can be effective in the treatment of congenital dacryoceles; 76% of dacryoceles in this series resolved after 6 days of medical management.
authors.affiliation: Department of Pediatric Ophthalmology, Wills Eye Hospital, Philadelphia, PA 19107, USA.
authors.forename: B M
authors.initials: BM
authors.lastname: Schnall
authors.forename: C J
authors.initials: CJ
authors.lastname: Christian
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001458:Bandages; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007767:Lacrimal Duct Obstruction / Q000151:congenital* / Q000628:therapy*; D008297:Male; D008405:Massage; D009301:Nasolacrimal Duct; D009883:Ophthalmic Solutions; D011446:Prospective Studies
chemical_list: D000900:Anti-Bacterial Agents; D009883:Ophthalmic Solutions